Trials / Completed
CompletedNCT01744756
Subconjunctival Bevacizumab and Recurrent Pterygium
Interventional Trial of Subconjunctival Bevacizumab in Recurrent Pterygium
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Instituto de Olhos de Goiania · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A study to research whether subconjunctival bevacizumab injection may potentially suppress neovascularization in pterygium, retarding and decreasing the size of recurrent pterygium.
Detailed description
1. Pacients with recurrent pterygium 2. Anti-VEGF therapy -Bevacizumab
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bevacizumab | One subconjunctival aplication of Bevacizumabe 0,5ml |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2012-07-01
- Completion
- 2012-09-01
- First posted
- 2012-12-07
- Last updated
- 2012-12-07
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01744756. Inclusion in this directory is not an endorsement.